Univariable | Multivariable | |||||
---|---|---|---|---|---|---|
HR | 95% CI | p-value | HR | 95% | p-value | |
Age | 1.03 | (1.01–1.06) | 0.015 | |||
Preop PSA | 1.02 | (1.01–1.03) | < 0.001 | |||
Year of treatment | 1.10 | (1.02–1018) | 0.012 | |||
Pathological Gleason Score | ||||||
≤6 | REF | REF | ||||
3 + 4 | 3.36 | (2.00–5.64) | < 0.001 | 2.86 | (1.68–4.88) | < 0.001 |
4 + 3 | 7.21 | (4.13–12.60) | < 0.001 | 3.88 | (2.12–7.07) | < 0.001 |
≥8 | 13.75 | (7.96–23.74) | < 0.001 | 7.97 | (4.38–14.51) | < 0.001 |
Stage pT | ||||||
pT2 | REF | REF | ||||
pT3a | 3.12 | (2.06–4.73) | < 0.001 | 2.28 | (1.48–3.52) | < 0.001 |
pT3b & pT4a | 7.37 | (4.89–11.12) | < 0.001 | 3.07 | (1.93–4.90) | < 0.001 |
Involvment of lymph nodes | 8.84 | (4.57–17.12) | < 0.001 | 3.42 | (1.70–6.91) | < 0.001 |
Apical margins | ||||||
focal | 1.10 | (0.63–1.92) | 0.742 | 0.86 | (0.49–1.50) | 0.586 |
extensive | 3.80 | (2.13–6.77) | < 0.001 | 2.62 | (1.40–4.90) | 0.003 |
Posterolateral margins | ||||||
focal | 2.59 | (1.62–4.14) | < 0.001 | |||
extensive | 2.73 | (1.46–5.08) | 0.002 | |||
Base margins | ||||||
focal | 2.60 | (1.40–4.84) | 0.003 | |||
extensiveb | 1.45 | (0.46 – 4.58) | 0.525 | |||
Neck margins | ||||||
focal | 1.55 | (0.21–10.98) | 0.67 | |||
extensivec |